Physician profile
Ryan C Vaughn
NPI 1487834958
$153,893.32
in general payments reported to CMS, 2019-2025
22 companies · $16K in 2025
The $16K reported for 2025 was more than what 98% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,757 · 2020: $5,804 · 2021: $57K · 2022: $58K · 2023: $2,677 · 2024: $9,374 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $8,293 · Food and Beverage: $7,366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,500.00 |
| Travel and Lodging | $8,292.61 |
| Food and Beverage | $7,366.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $69,194.43 | 2019-2022 | |
| Acclarent, INC | $24,736.16 | 2019-2024 | Trudi Nav Cable, Acclarent Aera, Relieva Spinplus |
| Aerin Medical INC. | $24,628.43 | 2019-2025 | |
| Neurent Medical Limited | $9,998.55 | 2023-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Stryker Corporation | $7,802.42 | 2019-2025 | Latera, Scopis Ent, N/A |
| Integra Lifesciences Corporation | $6,786.48 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Optinose US, INC. | $4,301.08 | 2019-2021 | |
| Intersect Ent, INC. | $2,800.08 | 2019-2021 | |
| Medtronic, INC. | $1,224.90 | 2023-2025 | Nuvent, Propel, Sinuva |
| Glaxosmithkline, LLC. | $812.69 | 2022-2025 | Nucala |
| Genzyme Corporation | $809.20 | 2023-2025 | |
| Abbvie INC. | $276.24 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $165.10 | 2021-2025 | Dupixent |
| Alk-Abello, INC | $67.27 | 2021-2022 | |
| Genentech USA, INC. | $59.93 | 2023-2025 | Xolair |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $55.00 | 2023-2025 | Watchpatone |
| Ethicon US, LLC | $52.85 | 2019 | |
| Hikma Pharmaceuticals USA | $34.30 | 2023 | Ryaltris |
| Astrazeneca Pharmaceuticals LP | $25.00 | 2025 | Tezspire |
| Karl Storz Endoscopy-America | $24.05 | 2024 | Hopkins |
| Boston Scientific Corporation | $21.45 | 2022 | |
| Lilly USA, LLC | $17.71 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Vaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.